These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17394605)

  • 41. [Diagnosis of invasive aspergillosis].
    Yoshida K
    Med Mycol J; 2013; 54(4):323-7. PubMed ID: 24292133
    [No Abstract]   [Full Text] [Related]  

  • 42. [Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].
    Jarque I; Andreu R; Salavert M; Gómez D; Pemán J; Gobernado M; Sanz MA
    Rev Iberoam Micol; 2003 Sep; 20(3):116-8. PubMed ID: 15456368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnosis of invasive aspergillosis by galactomannan antigenemia detection using an enzyme immunoassay.
    Wheat LJ; Walsh TJ
    Eur J Clin Microbiol Infect Dis; 2008 Apr; 27(4):245-51. PubMed ID: 18193305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design issues in a randomized controlled trial of a pre-emptive versus empiric antifungal strategy for invasive aspergillosis in patients with high-risk hematologic malignancies.
    Morrissey CO; Chen SC; Sorrell TC; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Schwarer AP; Slavin MA
    Leuk Lymphoma; 2011 Feb; 52(2):179-93. PubMed ID: 21281234
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis.
    Rohrlich P; Sarfati J; Mariani P; Duval M; Carol A; Saint-Martin C; Bingen E; Latge JP; Vilmer E
    Pediatr Infect Dis J; 1996 Mar; 15(3):232-7. PubMed ID: 8852911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical utility and development of biomarkers in invasive aspergillosis.
    Patterson TF
    Trans Am Clin Climatol Assoc; 2011; 122():174-83. PubMed ID: 21686223
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined real-time PCR and galactomannan surveillance improves diagnosis of invasive aspergillosis in high risk patients with haematological malignancies.
    Rogers TR; Morton CO; Springer J; Conneally E; Heinz W; Kenny C; Frost S; Einsele H; Loeffler J
    Br J Haematol; 2013 May; 161(4):517-24. PubMed ID: 23614624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial.
    Morrissey CO; Chen SC; Sorrell TC; Milliken S; Bardy PG; Bradstock KF; Szer J; Halliday CL; Gilroy NM; Moore J; Schwarer AP; Guy S; Bajel A; Tramontana AR; Spelman T; Slavin MA;
    Lancet Infect Dis; 2013 Jun; 13(6):519-28. PubMed ID: 23639612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.
    Huppler AR; Fisher BT; Lehrnbecher T; Walsh TJ; Steinbach WJ
    J Pediatric Infect Dis Soc; 2017 Sep; 6(suppl_1):S32-S44. PubMed ID: 28927202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies.
    Manso E; Montillo M; De Sio G; D'Amico S; Discepoli G; Leoni P
    Eur J Clin Microbiol Infect Dis; 1994 Sep; 13(9):756-60. PubMed ID: 7843181
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Investigation of Aspergillus galactomannan levels in antimicrobial agents].
    Yücesoy M; Ergon MC
    Mikrobiyol Bul; 2007 Oct; 41(4):565-70. PubMed ID: 18173075
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer.
    Woods G; Miceli MH; Grazziutti ML; Zhao W; Barlogie B; Anaissie E
    Cancer; 2007 Aug; 110(4):830-4. PubMed ID: 17607669
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
    Xie LP; Liu T; Meng WT; Zhou J
    Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aspergillosis: advances in immunological diagnosis and therapeutic measures.
    Feuilhade de Chauvin M
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):9-11. PubMed ID: 8511045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The use of galactomannan detection in diagnosing invasive aspergillosis in hemato-oncological patients].
    Rácil Z; Kocmanová I; Wagnerová B; Winterová J; Lengerová M; Moulis M; Mayer J
    Vnitr Lek; 2008 Jan; 54(1):45-52. PubMed ID: 18390117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic value of serum galactomannan, (1,3)-β-d-glucan, and Aspergillus fumigatus-specific IgA and IgG assays for invasive pulmonary aspergillosis in non-neutropenic patients.
    Dobias R; Jaworska P; Tomaskova H; Kanova M; Lyskova P; Vrba Z; Holub C; Svobodová L; Hamal P; Raska M
    Mycoses; 2018 Aug; 61(8):576-586. PubMed ID: 29575150
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients.
    Chen SC; Kontoyiannis DP
    Curr Opin Infect Dis; 2010 Dec; 23(6):567-77. PubMed ID: 20827189
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].
    Rácil Z; Kocmanová I; Weinbergerová B; Winterová J; Lengerová M; Hrncírová K; Mayer J
    Klin Mikrobiol Infekc Lek; 2009 Apr; 15(2):48-57. PubMed ID: 19488961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of PCR, (1-->3)-beta-D-glucan and galactomannan assays in sera of rats with experimental invasive aspergillosis.
    Hashimoto A; Yamakami Y; Kamberi P; Yamagata E; Karashima R; Nagaoka H; Nasu M
    J Clin Lab Anal; 1998; 12(5):257-62. PubMed ID: 9773954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.